Lymphomatoid Granulomatosis Induced by Imatinib-Treatment
Authors:
- Amir S. YazdiAYAmir S. Yazdi
- Gisela MetzlerGMGisela Metzler
- Susanne WeyrauchSWSusanne Weyrauch
- Mark BerneburgMBMark Berneburg
- Michael BitzerMBMichael Bitzer
- Hans-Konrad Müller-HermelinkHMHans-Konrad Müller-Hermelink
- Martin RöckenMRMartin Röcken
- 1 September 2007
- journal article
- other
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 143 (9) , 1209-1226
Abstract
An 89-year-old woman with liver metastases from a gastrointestinal stromal tumor (GIST) was treated with imatinib mesylate, initial dose of 400 mg/d. Three montKeywords
This publication has 4 references indexed in Scilit:
- Concomitant eosinophilia, fasciitis, and mycosis fungoides-like reaction with antinuclear autoantibodies in chronic myeloid leukaemia: role of a T-cell clone induced by imatinibThe Lancet Oncology, 2005
- Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent mannerBlood, 2005
- EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylateBlood, 2003
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001